KALA BIO, Inc. (KALA)

KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $5.48 million. The enterprise value is $3.46 million.

Market Cap	5.48M
Enterprise Value	3.46M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, before market open.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

KALA BIO has 7.02 million shares outstanding. The number of shares has increased by 99.78% in one year.

Current Share Class	7.02M
Shares Outstanding	7.02M
Shares Change (YoY)	+99.78%
Shares Change (QoQ)	+2.64%
Owned by Insiders (%)	0.80%
Owned by Institutions (%)	29.11%
Float	5.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.10

Current Ratio	2.10
Quick Ratio	2.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.04

Financial Efficiency

Return on equity (ROE) is -708.34% and return on invested capital (ROIC) is -65.62%.

Return on Equity (ROE)	-708.34%
Return on Assets (ROA)	-51.90%
Return on Invested Capital (ROIC)	-65.62%
Return on Capital Employed (ROCE)	-202.38%
Revenue Per Employee	n/a
Profits Per Employee	-$979,658
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.61% in the last 52 weeks. The beta is -2.11, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y)	-2.11
52-Week Price Change	-88.61%
50-Day Moving Average	8.19
200-Day Moving Average	6.47
Relative Strength Index (RSI)	26.62
Average Volume (20 Days)	726,659

Short Selling Information

The latest short interest is 893,238, so 12.72% of the outstanding shares have been sold short.

Short Interest	893,238
Short Previous Month	1.68M
Short % of Shares Out	12.72%
Short % of Float	16.70%
Short Ratio (days to cover)	0.37

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.55M
Pretax Income	-37.23M
Net Income	-37.23M
EBITDA	-40.28M
EBIT	-40.55M
Earnings Per Share (EPS)	-$6.71

Balance Sheet

The company has $31.94 million in cash and $29.93 million in debt, giving a net cash position of $2.01 million or $0.29 per share.

Cash & Cash Equivalents	31.94M
Total Debt	29.93M
Net Cash	2.01M
Net Cash Per Share	$0.29
Equity (Book Value)	-3.21M
Book Value Per Share	-0.48
Working Capital	17.65M

Cash Flow

In the last 12 months, operating cash flow was -$25.88 million and capital expenditures -$175,000, giving a free cash flow of -$26.06 million.

Operating Cash Flow	-25.88M
Capital Expenditures	-175,000
Free Cash Flow	-26.06M
FCF Per Share	-$3.71

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-99.78%
Shareholder Yield	-99.78%
Earnings Yield	-679.77%
FCF Yield	-475.79%

Analyst Forecast

The average price target for KALA BIO is $31.50, which is 3,938.46% higher than the current price. The consensus rating is "Buy".

Price Target	$31.50
Price Target Difference	3,938.46%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 1:50.

Last Split Date	Oct 21, 2022
Split Type	Reverse
Split Ratio	1:50

Scores

Altman Z-Score	n/a
Piotroski F-Score	2